Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

Avant Brands Expands Global Footprint with BLK MKT(TM) Launch in Australia
Healthcare & PharmaceuticalCompany Update

Avant Brands Expands Global Footprint with BLK MKT(TM) Launch in Australia

September 23, 2024 7:30 AM

KELOWNA, BC and MELBOURNE, AUSTRALIA / ACCESSWIRE / September 23, 2024 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading Canadian producer of award-winning, craft cannabis products, today announced that it has entered into an exclusive trademark licensing agreement with Nectar Portfolio Pty Ltd. ("Nectar"), a leading Australian medicinal cannabis importer and distributor. This landmark agreement marks...

Read more
Science & Humans Proudly Welcomes Renowned Healthcare Leader Karim
Healthcare & PharmaceuticalCompany Update

Science & Humans Proudly Welcomes Renowned Healthcare Leader Karim "Matt" Nassar as Chief Growth Officer

September 23, 2024 7:05 AM

Science & Humans (S&H), Canada's leading platform for hormone health, is excited to announce the appointment of Karim (Matt) Nassar as Chief Growth Officer. He joins S&H at a key inflection point as it looks to bring its leading direct-to-consumer hormone health program to private payers, brokers, and plan sponsors such as employers, unions and associations. Hormone health affects every aspect of an individual's quality of life which...

Read more
Xtant Medical Expands Product Portfolio with the Launch of the Cortera(R) Posterior Fixation System
Healthcare & PharmaceuticalProduct Announcements

Xtant Medical Expands Product Portfolio with the Launch of the Cortera(R) Posterior Fixation System

September 23, 2024 7:00 AM

New System Enhances Surgical Efficiency and Provides Versatile Solutions for Complex Spine ProceduresBELGRADE, MT / ACCESSWIRE / September 23, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a leading global medical technology company focused on the treatment of spinal disorders, is excited to announce the launch of the Cortera Posterior Fixation System, a comprehensive solution designed to streamline thoracolumbar fixation surgeries....

Read more
Angle PLC Announces Exclusive agreement for DNA NGS panel
Healthcare & PharmaceuticalRegulatory

Angle PLC Announces Exclusive agreement for DNA NGS panel

September 23, 2024 2:00 AM

ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, is delighted to announce that it has signed an agreement with the cutting-edge genomics and molecular diagnostics company, NuProbe USA, Inc. ("NuProbe"), to use its proprietary pan-cancer next generation sequencing (NGS) panel ("the NGS panel").Under the terms...

Read more
Relief Therapeutics Announces $2 Million Milestone Under Royalty Sales Agreement
Healthcare & PharmaceuticalCompany Update

Relief Therapeutics Announces $2 Million Milestone Under Royalty Sales Agreement

September 23, 2024 1:20 AM

RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced it will receive a $2 million milestone payment from SWK Funding LLC (SWK) this month, following the U.S. Food and Drug Administration's (FDA) approval of Zevra Therapeutics Inc.'s arimoclomol for the treatment of...

Read more
Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Healthcare & PharmaceuticalEarnings

Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024

September 20, 2024 5:40 PM

HILLSIDE, NJ / ACCESSWIRE / September 20, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2024.Revenue for the quarter ended June 30, 2024 was $12.7 million compared to $13.0 million for the quarter ended June 30, 2023, a decrease of $0.3 million or 2.3%. The Company had operating income of approximately $402,000 and $79,000 in the quarters...

Read more
Leafbuyer Technologies, Inc. Announces Quarterly Results
Healthcare & PharmaceuticalEarnings

Leafbuyer Technologies, Inc. Announces Quarterly Results

September 20, 2024 4:10 PM

Leafbuyer Technologies Inc. ("Leafbuyer" or "the Company") (OTCQB:LBUY), a leading cannabis technology company, announced today that revenue grew 16.4% and gross profit increased by 9% in the quarter ending March 31,2024.Leafbuyer's 16.4%% year-over-year revenue growth rate is nearly double the industry's projected compound annual growth rate of 8.5%, according to New Frontier Data. Increased sales of the Company's loyalty, texting, online...

Read more
Dr. Vitenas Provides Insight Into Emerging 'Yoga' or 'Ballerina' Breast Augmentation Trend
Healthcare & PharmaceuticalCompany Update

Dr. Vitenas Provides Insight Into Emerging 'Yoga' or 'Ballerina' Breast Augmentation Trend

September 20, 2024 2:15 PM

Dr. Paul Vitenas Unveils 'Yoga Boobs' Trend for Natural, Athletic Breast Augmentation Using Cutting-Edge TechniquesHOUSTON, TX / ACCESSWIRE / September 20, 2024 / Dr. Paul Vitenas, a board-certified plastic surgeon at Vitenas Cosmetic Surgery in Houston, Texas, sheds light on a new breast augmentation trend called "yoga boobs" or "ballerina boobs." This approach can create perky, proportionate, and natural-looking breasts that maintain their...

Read more
Bevel, The Award-Winning Men's Grooming Brand Supports Invest Fest Entrepreneurs with $25,000 Grant
Healthcare & PharmaceuticalCompany Update

Bevel, The Award-Winning Men's Grooming Brand Supports Invest Fest Entrepreneurs with $25,000 Grant

September 20, 2024 12:15 PM

ATLANTA, GA / ACCESSWIRE / September 20, 2024 / Atlanta-based, leading men's head-to-toe grooming brand Bevel, is proud to present a $25,000 business grant to marketplace vendor Double Dutch Aerobics. Invest Fest is a first of its kind, in-person experience that combines investing, entrepreneurship, pop culture, and entertainment in a festival setting. The festival is where commerce and culture meet at a unique intersection for the empowerment...

Read more
Quest Diagnostics Elevates Employee Well-Being With Relaunched HealthyQuest Program, Holistic Support Initiatives, and High Engagement in 2023
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Quest Diagnostics Elevates Employee Well-Being With Relaunched HealthyQuest Program, Holistic Support Initiatives, and High Engagement in 2023

September 20, 2024 11:30 AM

NORTHAMPTON, MA / ACCESSWIRE / September 20, 2024 / Quest Diagnostics:Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportWe conducted a comprehensive benefits survey to better understand what our employees are looking for and determine how we can better meet their needs. In 2023, we implemented new initiatives and enhanced existing ones to address the physical and financial well-being topics our employees...

Read more
ZetrOZ Systems Provides Targeted Treatment for Common Sports Injuries
Healthcare & PharmaceuticalCompany Update

ZetrOZ Systems Provides Targeted Treatment for Common Sports Injuries

September 20, 2024 9:30 AM

The sam® wearable ultrasound biotechnology is purpose-built to treat the most common athletic injuries, accelerating soft tissue healing and reducing the need for surgery or pain medication.TRUMBULL, CT / ACCESSWIRE / September 20, 2024 / With several sports seasons starting up, ZetrOZ Systems, creators of sustained acoustic medicine and the sam® wearable ultrasound treatment for soft tissue healing, offers guidance on the precise placement of...

Read more
Water Tower Research Highlights Ainos VELDONA Clinical Trial for HIV+ Patients with Oral Warts
Healthcare & PharmaceuticalCompany Update

Water Tower Research Highlights Ainos VELDONA Clinical Trial for HIV+ Patients with Oral Warts

September 20, 2024 8:00 AM

Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an innovative healthcare company focused on advanced AI-driven point-of-care testing ("POCT") and low-dose interferon therapeutics, today announced that Water Tower Research ("WTR") has issued a note on the Company's upcoming clinical trial for VELDONA®, a low-dose oral interferon-alpha formulation, in treating oral warts in HIV+ patients on antiretroviral therapy ("ART").The...

Read more
Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch
Healthcare & PharmaceuticalCompany Update

Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch

September 20, 2024 6:50 AM

Nutriband signs trademark licensing agreement for Bitrex® brand denatonium benzoate, the most bitter substance in the world, as an aversive agent for its Aversa™ Fentanyl abuse deterrent fentanyl transdermal patchNutriband abuse-deterrent transdermal technology consists of a proprietary aversive agent coating that employs taste aversion to deter the oral abuse of and accidental exposure to transdermal opioid and stimulant patch productsORLANDO,...

Read more
Press Release for The Changing Face of Addiction VIRTUAL Summit
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Press Release for The Changing Face of Addiction VIRTUAL Summit

September 19, 2024 9:30 PM

This dynamic online event is designed to challenge outdated perceptions and shine a light on the multifaceted nature of addiction in today's world. Immerse yourself in a series of powerful talks, interactive workshops, and real-life stories that highlight innovative approaches to treatment, the importance of mental health, and the role of community and support systems. Discover cutting-edge research, holistic recovery strategies, and the...

Read more
Aytu BioPharma to Report Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results on September 26, 2024
Healthcare & PharmaceuticalConference Call

Aytu BioPharma to Report Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results on September 26, 2024

September 19, 2024 5:30 PM

DENVER, CO / ACCESSWIRE / September 19, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report its operational and financial results for its fiscal 2024 full year and fourth quarter, after the market close on Thursday, September 26, 2024. The Company has scheduled a conference call and webcast that same day, Thursday, September 26, 2024, at 4:30...

Read more
Theralase(R) Extends Warrants
Healthcare & PharmaceuticalCompany Update

Theralase(R) Extends Warrants

September 19, 2024 5:05 PM

Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light, radiation, sound and/or drug-activated small molecules and their formulations, intended for the safe and effective destruction of various cancers, bacteria and viruses, is pleased to announce that the Company proposes to extend the expiry date of 10,000,000 share purchase...

Read more
Tenon Medical Announces Issuance of Three Notices of Allowance for Patent Applications from the USPTO
Healthcare & PharmaceuticalCompany Update

Tenon Medical Announces Issuance of Three Notices of Allowance for Patent Applications from the USPTO

September 19, 2024 4:05 PM

Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced the United States Patent and Trademark Office ("USPTO") issued three (3) Notices of Allowance for U.S. Patent Application Numbers 17,469,132 and 17/468,811, both entitled "Sacroiliac Joint Stabilization Prostheses", and 18/612,032, entitled "Systems, Apparatus and Methods...

Read more
Cosmos Health Enters Development Phase for CCDL24, an Innovative Multitargeting Product for Gastrointestinal Disorders, with a Market Size Valued at Over $37.5 Billion
Healthcare & PharmaceuticalProduct Announcements

Cosmos Health Enters Development Phase for CCDL24, an Innovative Multitargeting Product for Gastrointestinal Disorders, with a Market Size Valued at Over $37.5 Billion

September 19, 2024 3:40 PM

Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has entered the development phase for CCDL24, an innovative treatment for gastrointestinal (GI) disorders.CCDL24...

Read more
San Francisco Medical Waste Disposal Firm Mitigates Increase in Needlestick Injuries With Key Resource
Healthcare & PharmaceuticalEnvironmental, Social and Governance

San Francisco Medical Waste Disposal Firm Mitigates Increase in Needlestick Injuries With Key Resource

September 19, 2024 1:11 PM

Each year, the CDC estimates that around 385,000 healthcare workers in the United States suffer from needlestick and sharps-related injuries.SAN FRANCISCO, CA / ACCESSWIRE / September 19, 2024 / With a surge in needlestick injuries becoming a pressing issue, BioMedical Waste Solutions, a top medical waste disposal company, with locations in San Francisco, CA, is actively informing the public about the dangers of improper medical waste disposal,...

Read more
Alzheimer’s Disease Research Foundation
Healthcare & PharmaceuticalCompany Update

Alzheimer’s Disease Research Foundation

September 19, 2024 12:15 PM

WELLESLEY HILLS, MA / ACCESSWIRE / September 19, 2024 / Tara Manufacturing, a leading innovator in pool and outdoor products, will present the largest donation in its history to Cure Alzheimer's Fund, a non-profit organization that funds research into Alzheimer's disease. The $338,384.01 donation represents the proceeds from the sales of Tara's Celestial Skies pattern, a unique product designed to support Alzheimer's research and honor the...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?